Private equity misses out on Lucozade, Ribena sale
GlaxoSmithKline (GSK) has agreed to sell popular drinks brands Lucozade and Ribena, which had attracted interest from buyout houses including Blackstone and Lion Capital, to Japanese trade player Suntory for ТЃ1.35bn.
More on Consumer
Big Bus tours bidders' interest ahead of September launch of sale process
Sponsor Exponent acquired the UK-based tour company in 2015 via the same-year vintage Exponent Private Equity Partners III
IK launches mini-cap strategy in UK and Benelux with robust pipeline
With a focus on deals of up to EUR 50m EV, the GP's Development Capital team is in advanced negotiations with several potential targets in the new markets
Investindustrial acquires majority stake in Eataly
EUR 200m investment will allow high-end food retailer retire debt and support global expansion
Foreign GPs step up for large Italian deals – panel
Interest from international players is growing across a variety of sectors, but political uncertainty looms
Latest News
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Czech Republic-headquartered family office is targeting DACH and CEE region deals
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Ex-Rocket Internet leader Bettina Curtze joins Swiss VC firm as partner and CFO
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Estonia-registered VC could bolster LP base with fresh capital from funds-of-funds or pension funds